Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
de Haas SL, de Visser SJ, van der Post JP, de Smet M, Schoemaker RC, Rijnbeek B, Cohen AF, Vega JM, Agrawal NG, Goel TV, Simpson RC, Pearson LK, Li S, Hesney M, Murphy MG, van Gerven JM.
de Haas SL, et al. Among authors: de smet m, de visser sj.
J Psychopharmacol. 2007 Jun;21(4):374-83. doi: 10.1177/0269881106072343. Epub 2006 Nov 8.
J Psychopharmacol. 2007.
PMID: 17092968
Clinical Trial.